<DOC>
	<DOCNO>NCT00312572</DOCNO>
	<brief_summary>The objective study evaluate safety efficacy dose conversion hydrocodone/ acetaminophen ( Vicodin® ) buprenorphine transdermal system ( Butrans™ ) subject osteoarthritis pain hip knee . The double-blind treatment intervention duration 2 week time supplemental analgesic medication allow .</brief_summary>
	<brief_title>Safety Efficacy Dose Conversion From Vicodin® Buprenorphine Transdermal System ( Butrans™ ) Subjects With OA Pain</brief_title>
	<detailed_description>Buprenorphine synthetic opioid analgesic 25 year international clinical experience indicate safe effective variety therapeutic situation relief moderate severe pain .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Acetaminophen , hydrocodone drug combination</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>osteoarthritis hip knee take regularly schedule regimen hydrocodone/ acetaminophen osteoarthritis OA pain . currently condition require stable regimen acetaminophen ( APAP ) . history chronic condition , OA hip knee joint , require frequent , intermittent analgesic therapy . Other protocolspecific exclusion/inclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Osteoarthritis , opioid , transdermal</keyword>
</DOC>